156 related articles for article (PubMed ID: 12227709)
1. Effects of anti-vasospastic agents in Japanese patients with dilated cardiomyopathy and coronary vasospasm.
Nishi I; Ilda K; Kawano S; Masumi T; Fumikura Y; Ohtsuka S; Watanabe S; Yamaguchi I
Jpn Heart J; 2002 Jul; 43(4):333-42. PubMed ID: 12227709
[TBL] [Abstract][Full Text] [Related]
2. Diffuse and severe left ventricular dysfunction induced by epicardial coronary artery spasm.
Sakata K; Nawada R; Ohbayashi K; Tamekiyo H; Yoshida H
Angiology; 2000 Oct; 51(10):837-47. PubMed ID: 11108328
[TBL] [Abstract][Full Text] [Related]
3. Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina.
Watanabe K; Takahashi T; Miyajima S; Hirokawa Y; Tanabe N; Kato K; Kodama M; Aizawa Y; Tazawa S; Inoue M
J Nucl Med; 2002 Nov; 43(11):1476-81. PubMed ID: 12411551
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular dysfunction due to diffuse multiple vessel coronary artery spasm can be concealed in dilated cardiomyopathy.
Inami T; Kataoka M; Shimura N; Ishiguro H; Kohshoh H; Taguchi H; Yanagisawa R; Hara Y; Satoh T; Yoshino H
Eur J Heart Fail; 2012 Oct; 14(10):1130-8. PubMed ID: 22713288
[TBL] [Abstract][Full Text] [Related]
5. [Diffuse left ventricular hypokinesis mimicking dilated cardiomyopathy with multi-vessel coronary vasospasm].
Shimizu M; Kawata M; Okada T; Mizutani T
J Cardiol; 2000 Jun; 35(6):409-15. PubMed ID: 10884977
[TBL] [Abstract][Full Text] [Related]
6. Coronary vasospasm: a case report and review of the literature.
Van Spall HG; Overgaard CB; Abramson BL
Can J Cardiol; 2005 Sep; 21(11):953-7. PubMed ID: 16239980
[TBL] [Abstract][Full Text] [Related]
7. Comparison of coronary flow reserve between focal and diffuse vasoconstriction induced by ergonovine in patients with vasospastic angina.
Akasaka T; Yoshida K; Hozumi T; Takagi T; Kawamoto T; Kaji S; Morioka S; Yoshikawa J
Am J Cardiol; 1997 Sep; 80(6):705-10. PubMed ID: 9315573
[TBL] [Abstract][Full Text] [Related]
8. [Coronary spasm and heart arrest caused by ventricular fibrillation].
Vara J; Alvarez G; Lambert JL; Espolita A; Rubín JM; Posada IS; Cortina A; Morís C
Rev Esp Cardiol; 1998 May; 51(5):410-3. PubMed ID: 9644968
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of Vasospastic Angina.
Harris JR; Hale GM; Dasari TW; Schwier NC
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):439-51. PubMed ID: 27081186
[TBL] [Abstract][Full Text] [Related]
10. Ergonovine-testing-directed therapy and long-term outcome of sudden-death survivors with no apparent heart disease.
Ritchie ME; Hattemer C; Lenihan D
Cardiology; 1998; 89(1):76-8. PubMed ID: 9452162
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of familial hypertrophic cardiomyopathy and vasospastic angina pectoris in two brothers.
Suzuki N; Seto S; Koide Y; Sato O; Hirano H; Kawano H; Yano K
Jpn Heart J; 2003 Sep; 44(5):775-82. PubMed ID: 14587659
[TBL] [Abstract][Full Text] [Related]
12. The 24-Month Prognosis of Patients With Positive or Intermediate Results in the Intracoronary Ergonovine Provocation Test.
Shin DI; Baek SH; Her SH; Han SH; Ahn Y; Park KH; Kim DS; Yang TH; Choi DJ; Suh JW; Kwon HM; Lee BK; Gwon HC; Rha SW; Jo SH
JACC Cardiovasc Interv; 2015 Jun; 8(7):914-23. PubMed ID: 26003026
[TBL] [Abstract][Full Text] [Related]
13. Significance of coronary artery tone in patients with vasospastic angina.
Hoshio A; Kotake H; Mashiba H
J Am Coll Cardiol; 1989 Sep; 14(3):604-9; discussion 610-2. PubMed ID: 2768710
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical characteristics and prognosis in Taiwanese patients with coronary vasospastic angina pectoris without significant fixed coronary artery disease versus patients with significant fixed coronary artery disease and either stable angina pectoris or acute coronary syndromes.
Hung MJ; Hung MY; Cheng CW; Yang NI; Cherng WJ
Am J Med Sci; 2007 Sep; 334(3):160-7. PubMed ID: 17873528
[TBL] [Abstract][Full Text] [Related]
15. Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test.
Io K; Minatoguchi S; Nishigaki K; Ojio S; Tanaka T; Segawa T; Matsuo H; Watanabe S; Hattori A; Ueno K; Ono H; Hiei K; Sato H; Morita N; Noda T; Kato T; Kawasaki M; Takemura G; Fujiwara H
Arzneimittelforschung; 2007; 57(9):573-81. PubMed ID: 17966756
[TBL] [Abstract][Full Text] [Related]
16. Low prevalence of coronary artery spasm in patients with normal coronary angiograms and unexplained ventricular fibrillation.
Peters RH; Wever EF; Hauer RN; Robles de Medina EO
Eur Heart J; 1998 Jul; 19(7):1070-4. PubMed ID: 9717043
[TBL] [Abstract][Full Text] [Related]
17. Ergonovine echocardiography as a screening test for diagnosis of vasospastic angina before coronary angiography.
Song JK; Lee SJ; Kang DH; Cheong SS; Hong MK; Kim JJ; Park SW; Park SJ
J Am Coll Cardiol; 1996 Apr; 27(5):1156-61. PubMed ID: 8609335
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association.
Takahashi J; Nihei T; Takagi Y; Miyata S; Odaka Y; Tsunoda R; Seki A; Sumiyoshi T; Matsui M; Goto T; Tanabe Y; Sueda S; Momomura S; Yasuda S; Ogawa H; Shimokawa H;
Eur Heart J; 2015 Jan; 36(4):228-37. PubMed ID: 25189599
[TBL] [Abstract][Full Text] [Related]
19. Multiple coronary vasospasm: a cause of repeated myocardial infarction and symptomatic 'torsade de pointes' (atypical ventricular tachycardia). A case presentation and review.
Przybojewski JZ
S Afr Med J; 1983 Jan; 63(4):103-12. PubMed ID: 6336853
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic study and ergonovine provocation of coronary spasm in unexplained syncope.
Watanabe K; Inomata T; Miyakita Y; Takahashi M; Suzuki T; Koyama S; Ohshima M; Suzuki K; Masani F; Aizawa Y
Jpn Heart J; 1993 Mar; 34(2):171-82. PubMed ID: 8315814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
